Tiludronic acid is a bisphosphonate used for treatment of Paget's disease of bone
(osteitis deformans) in human medicine. It has the tradename Skelid.
Description, Tiludronate is a bisphosphonate characterized by a (4-
chlorophenylthio) group on the carbon atom of the basic P-C-P structure common
to all ...
Nov 15, 2015 ... Tiludronate is used to treat Paget's disease of bone (a condition in which the
bones are soft and weak and may be deformed, painful, or easily ...
Apr 14, 2010 ... SKELID (tiludronate) is a bisphosphonate characterized by a (4-chlorophenylthio
) group on the carbon atom of the basic P-C-P structure ...
Consumer information about the medication TILUDRONATE - ORAL (Skelid),
includes side effects, drug interactions, recommended dosages, and storage ...
Sigma-Aldrich offers Sigma-T4580, Tiludronate disodium salt hydrate for your
research needs. Find product specific information including CAS, MSDS,
Equine Vet J. 2003 Jun;35(4):407-13. Tiludronate as a new therapeutic agent in
the treatment of navicular disease: a double-blind placebo-controlled clinical ...
Apr 10, 2008 ... Tiludronate is a compound in the bisphosphonate class of drugs. The main
pharmacologic action of bisphosphonates is to inhibit bone ...
SKELID tablets for oral administration contain 240 mg tiludronate disodium,
which is the molar equivalent of 200 mg tiludronic acid. SKELID tablets also
Medscape - Indication-specific dosing for Skelid (tiludronate), frequency-based
adverse effects, comprehensive interactions, contraindications, pregnancy ...